ISPOR Europe 2025 Home
  • About
    • Registration Information
    • News Center
  • Program
    • Program
    • Plenary Sessions
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsors
    • Media Partners
    • Exhibitor Directory
  • Photo Gallery
  • Award Winners
large-circle

ISPOR Europe 2025

9 - 12 November

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Europe 2026
  • Program
  • Paper
  • Changes in Physical Activity of Pediatric Patients Treated With Damoctocog Alfa Pegol During the Alfa-PROTECT Clinical Trial

    Sep 9, 2025, 16:22 PM
  • Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0

    Sep 9, 2025, 16:22 PM
  • Health Technology Assessment Landscape for Medical Devices in Europe

    Sep 9, 2025, 16:22 PM
  • Approaches Used in Assessing the Environmental Sustainability of Digital Health Technologies: A Systematic Review

    Sep 9, 2025, 16:22 PM
  • Cardiovascular Event Rate and Mortality Among Primary-Prevention Hypercholesterolemia Patients in Japan

    Sep 9, 2025, 16:22 PM
  • Bayesian Dynamic Borrowing to Enhance Evidence for New Therapies

    Sep 9, 2025, 16:22 PM
  • Informing Health System Reform Through Patient Perspectives: Saudi Arabia’s OECD Paris Survey Results

    Sep 9, 2025, 16:22 PM
  • Investing in Diagnosis: Health Economic Value of Early Obstructive Sleep Apnea Detection for Private Insurers in India

    Sep 9, 2025, 16:22 PM
  • Cost-Effectiveness Analysis of FreeStyle Libre Systems vs. Self-Monitoring of Blood Glucose in People With Type 2 Diabetes on Basal Insulin: An Israeli Healthcare System Perspective

    Sep 9, 2025, 16:22 PM
  • Quality of Life in Patients With Severe Hemophilia A With Inhibitors Treated With Emicizumab in Mexico

    Sep 9, 2025, 16:22 PM
  • Economic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)

    Sep 9, 2025, 16:22 PM
  • Lessons From the NHS AI Awards: Experience of Evaluating AI Tools in Real-World Environments

    Sep 9, 2025, 16:22 PM
  • Insights on Progress Toward Patient-Centered HTA Through Evaluation of PRO Integration, Value Disconnects, and Policy Change in the EU5

    Sep 9, 2025, 16:22 PM
  • Which Country Is Currently Reporting the Lowest Global Prices for Semaglutide, and Why?

    Sep 9, 2025, 16:22 PM
  • A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices

    Sep 9, 2025, 16:22 PM
  • Comparing ROBINS-I V2 and Downs Black for nRCTs in the Context of HTA

    Sep 9, 2025, 16:22 PM
  • Unveiling the Economic Landscape: Burden of HR/HER2 Locally Recurrent Inoperable or Metastatic Breast Cancer

    Sep 9, 2025, 16:22 PM
  • Can an Ensemble Machine-Learning Approach Outperform Traditional Models While Enhancing Accuracy, Fairness, and Interpretability in Clinical Risk Prediction?

    Sep 9, 2025, 16:22 PM
  • Missed Opportunities in the Diagnosis and Management of Stage 3 Chronic Kidney Disease in General Practice: Insights From the Italian THIN Database

    Sep 9, 2025, 16:22 PM
  • Perspectives on Progress: A Qualitative Study of HIV Prevention Efforts in the Czech Republic

    Sep 9, 2025, 16:22 PM
  • «
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group